drugset / Trial / NCT06843590
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets
Timeline
- Start
- 2025-05-22
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALKS 2680 | Unknown | 10 mg | Oral |
| Subject | ALKS 2680 | Unknown | 14 mg | Oral |
| Subject | ALKS 2680 | Unknown | 18 mg | Oral |